心血管代谢共病与活动受限:加拿大老龄化纵向研究横断面分析
该研究基于加拿大老龄化纵向研究数据,纳入45-85岁成年人(n=50,777;加权n=13,118,474),评估心血管代谢共病(CM)与活动受限的关联。结果显示,CM患者活动受限患病率为27.4%,无心血管代谢疾病者为7.5%;CM患者活动受限的校正相对风险比为3.99(95%CI 3.35-4.75),且每增加一种疾病风险递增,卒中幸存者风险更高。
要点
- CM患者活动受限患病率为27.4%,显著高于无心血管代谢疾病者的7.5%。
- CM与活动受限的校正相对风险比为3.99(95%CI 3.35-4.75)。
- 活动受限的患病率、严重程度和风险随心血管代谢疾病数量增加而递增,卒中幸存者风险更高。
核心结论
- 心血管代谢共病(CM)患者活动受限常见,且每增加一种心血管代谢疾病,活动受限风险递增,卒中幸存者风险更高。
研究设计与样本
- 基于加拿大老龄化纵向研究的横断面分析,纳入45-85岁成年人(n=50,777;加权n=13,118,474)。
- CM定义为糖尿病/糖尿病前期、心肌梗死和卒中中至少2种诊断;活动受限采用Older Americans Resources and Services量表评估。
- 采用描述性统计及logistic和多分类logistic回归分析CM与活动受限的关联。
主要发现
- CM患者活动受限患病率为27.4%,无心血管代谢疾病者为7.5%。
- 活动受限的患病率和严重程度随心血管代谢疾病数量增加而增加。
- CM患者活动受限的校正相对风险比为3.99(95%CI 3.35-4.75),每增加一种疾病风险递增。
- 卒中幸存者相比无卒中史且心血管代谢疾病数量相同者,活动受限风险更高。
关键数值与推荐
- CM定义为糖尿病/糖尿病前期、心肌梗死和卒中中至少2种诊断。
- CM患者活动受限患病率27.4%,无心血管代谢疾病者7.5%。
- CM与活动受限的校正相对风险比=3.99(95%CI 3.35-4.75)。
临床怎么用
- 对CM患者应评估活动受限风险,尤其关注卒中幸存者。
- 鉴于卒中合并糖尿病/糖尿病前期和心肌梗死时活动受限风险增加,应特别努力管理有卒中史个体的慢性病风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiometabolic multimorbidity (CM) is the diagnosis of 2 or more cardiometabolic conditions. Multimorbidity and individual cardiometabolic conditions have been associated with activity limitation, a common form of disability, but few studies have investigated the association between CM and activity limitation. OBJECTIVES: To estimate the prevalence of activity limitation among Canadians with CM and to quantify the association between CM and activity limitation. METHODS: Using data from the Canadian Longitudinal Study on Aging, we conducted a cross-sectional analysis of activity limitation among Canadians aged 45-85 (n = 50,777; weighted n = 13,118,474). CM was defined as the diagnosis of 2 or more of diabetes/prediabetes, myocardial infarction, and stroke, and activity limitation was evaluated using the Older Americans Resources and Services scale. Descriptive statistics and logistic and multinomial logistic regression analyses were conducted to determine the association between CM and activity limitation. RESULTS: The estimated prevalence of activity limitation among participants living with CM was 27.4% compared with 7.5% with no cardiometabolic conditions. Activity limitation increased in prevalence and severity with the number of cardiometabolic conditions. People with CM had increased odds of activity limitation compared with those without any cardiometabolic conditions (adjusted relative risk ratio = 3.99, 95% confidence interval [3.35-4.75]), and the odds increased with each additional condition. Stroke survivors had greater odds of activity limitation than those without a history of stroke and the same number of cardiometabolic conditions. CONCLUSION: Activity limitation is common among Canadians living with CM. Odds of activity limitation increase with each additional cardiometabolic condition, especially for stroke survivors. Cardiometabolic multimorbidity (CM) is a common pattern of multimorbidity characterized by the diagnosis of 2 or more cardiometabolic conditions, such as stroke, diabetes, and myocardial infarction. Previous research has found that individuals with stroke, diabetes, or myocardial infarction are at an increased risk of activity limitation, defined by the World Health Organization as the “difficulties an individual may have in executing activities.” This study investigated the prevalence, risk, and severity of activity limitation among Canadians with CM and combinations of stroke, diabetes/prediabetes, and myocardial infarction. Using data from the Canadian Longitudinal Study on Aging, the estimated prevalence of activity limitation among those living with CM was 27.4% compared with 7.5% among individuals without any cardiometabolic conditions. Individuals living with CM also had increased odds of activity limitation compared with those with no cardiometabolic conditions. Importantly, the prevalence, severity, and risk of activity limitation increased with each additional condition, especially when the cluster of conditions included stroke, suggesting an additive effect of CM on activity limitation. Based on these findings, special efforts should be made to manage chronic disease risk in individuals with a history of stroke given the increased risk of activity limitation when combined with diabetes/prediabetes and myocardial infarction.
引用
- Fishbook BN, Brinton CD, Siever J, et al. Cardiometabolic multimorbidity and activity limitation: a cross-sectional study of adults using the Canadian Longitudinal Study on Aging data. Fam Pract. 2022. PMID: 34644392. doi:10.1093/fampra/cmab129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。